AI assistant
Medtronic plc — Director's Dealing 2015
Apr 15, 2015
29841_dirs_2015-04-15_9b95a130-6132-488a-a905-0dadc0982241.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2015-01-26
Reporting Person: ARNOLD CRAIG (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-26 | Ordinary Shares | A | 15154 | — | Acquired | 15154 | Direct |
Footnotes
F1: This balance was incorrectly reported as 16,635 and has been corrected.
F2: Represents shares of Medtronic plc ("New Medtronic") acquired pursuant to the merger (the "Merger", executed pursuant to the "Transaction Agreement") of a wholly-owned subsidiary of New Medtronic with and into Covidien plc ("Covidien"), with Covidien surviving as a wholly-owned subsidiary of New Medtronic, by means of a "scheme of arrangement", an Irish statutory procedure under the Companies Act of 1963. At the effective time of the Merger, each Covidien ordinary share was cancelled and converted into the right to receive 0.956 ordinary shares of New Medtronic and $35.19. Under the terms of the Transaction Agreement, Covidien shareholders received cash in lieu of fractional shares of New Medtronic.